slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 5,881-5,910
Pages 296
Rows per page 30
Slide type
5,881-5,910 of 8,880
06
The slide uses a three-column layout to present distinct technological approaches.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a structural biology visualization and two dose-response curves to establish bio-equivalence and differentiation.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a comparative table for safety metrics and a bar chart for ADA rates to establish clinical equivalence/safety.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
21
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
22
The funnel diagram illustrates the selection criteria: Monomer/Trimer binder -> Picomolar potency -> Extended half-life.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
28
The slide uses a biological process diagram to illustrate the mechanism of action for three distinct therapeutic assets.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
10
Includes structural biology visualization, dose-response curves, and a binding affinity table.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · Evidence & Proof1 hit
21
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
22
The slide uses a funnel diagram to illustrate the selection process from initial discovery sets to final candidate properties.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
23
The slide uses two distinct chart types: a scatter plot for binding affinity and a dose-response curve for functional inhibition.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
29
The slide uses a biological process diagram to map drug targets to specific cellular mechanisms (T-cell trafficking, Colonic Fibrosis, Inflammatory cascade, Th17 maturation).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
03
The slide outlines the core therapeutic strategy of Arbutus Biopharma.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a process-oriented flow diagram to explain the mechanism of action for a combination therapy.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide highlights the mechanism of action and key therapeutic benefits of the drug candidate.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Product1 hit
23
The slide uses a three-column layout to explain the scientific basis and product advantages.Arbutus Biopharma | Investor Presentation Deck | 25 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
07
Astra | Investor Presentation Deck | 22 slidesAstra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations Beat · Solution1 hit
11
The slide uses icons to represent each capability, paired with a photograph of the thruster in operation.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
19
The slide emphasizes the portability and operational efficiency of the launch system.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
07
Includes a map of global disease burden and specific clinical trial milestones.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
14
Includes a map of global disease burden and key product features.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
Includes a map of global disease burden and key epidemiological metrics for OUD.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
23
Includes a map of global disease burden and key product specs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
04
The slide uses a value chain framework to show disintermediation of traditional ad-tech layers.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a value-chain style layout to illustrate the flow from demand (advertisers/agencies) through the Azerion platform to supply (publishers).Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Solution1 hit
09
The slide uses a five-column layout to categorize the company's service offerings.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
12
The slide uses a funnel-like visual structure to categorize the value proposition.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
14
Uses a comparative structure to show breadth of service.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a comparison table to differentiate service tiers for publishers.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
20
Uses a value-chain diagram to contrast market complexity.Azerion | Investor Presentation Deck | 34 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit